• 1. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 2. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 3. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 4. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 5. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Isoxazoles

Recent Advances in the Application of 3-(Chloromethyl)isoxazole (CAS: 57684-71-6) in Chemical Biology and Pharmaceutical Research

The compound 3-(Chloromethyl)isoxazole (CAS: 57684-71-6) has recently garnered significant attention in chemical biology and pharmaceutical research due to its versatile reactivity and potential as a key intermediate in drug discovery. This heterocyclic compound, characterized by its isoxazole ring and reactive chloromethyl group, serves as a valuable building block for the synthesis of biologically active molecules. Recent studies have explored its applications in medicinal chemistry, particularly in the development of novel antimicrobial, anticancer, and anti-inflammatory agents.

One of the most notable advancements involves the use of 3-(Chloromethyl)isoxazole as a precursor for the synthesis of isoxazole-containing pharmacophores. Researchers have demonstrated its efficacy in click chemistry reactions, enabling the rapid assembly of diverse compound libraries for high-throughput screening. A 2023 study published in the Journal of Medicinal Chemistry highlighted its role in the development of potent kinase inhibitors, where the chloromethyl group facilitated efficient conjugation with target proteins, enhancing binding affinity and selectivity.

In addition to its synthetic utility, 3-(Chloromethyl)isoxazole has been investigated for its direct biological activities. Recent in vitro studies have shown that derivatives of this compound exhibit promising antimicrobial properties against drug-resistant bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA). The mechanism of action appears to involve interference with bacterial cell wall synthesis, as evidenced by electron microscopy and proteomic analyses. These findings suggest potential applications in addressing the global challenge of antibiotic resistance.

Another emerging area of research focuses on the compound's role in targeted drug delivery systems. Scientists have functionalized nanoparticles with 3-(Chloromethyl)isoxazole derivatives to achieve site-specific release of therapeutic agents. A 2024 study in Advanced Drug Delivery Reviews reported improved tumor accumulation and reduced off-target effects when these modified nanoparticles were used in murine models of breast cancer. The chloromethyl group's reactivity allowed for precise conjugation with targeting ligands, underscoring its value in nanomedicine.

Despite these promising developments, challenges remain in optimizing the stability and pharmacokinetic properties of 3-(Chloromethyl)isoxazole-derived compounds. Recent computational studies employing molecular dynamics simulations have provided insights into structural modifications that could enhance metabolic stability while maintaining biological activity. Furthermore, advances in green chemistry have led to more sustainable synthetic routes for this compound, reducing environmental impact without compromising yield or purity.

In conclusion, 3-(Chloromethyl)isoxazole (CAS: 57684-71-6) continues to be a molecule of great interest in chemical biology and pharmaceutical research. Its dual role as a synthetic intermediate and a biologically active scaffold positions it as a valuable tool for drug discovery and development. Ongoing research is expected to further elucidate its potential in addressing unmet medical needs, particularly in the areas of infectious diseases and oncology. The compound's versatility and the recent methodological advances in its application underscore its enduring relevance in the field.

• 35166-37-1(3-(chloromethyl)-5-methyl-1,2-oxazole)
• 53064-54-3(1,2-oxazole-3-carbonyl chloride)
• 2703782-14-1(4-Chloro-3-(chloromethyl)-1,2-oxazole)
• 30842-90-1(3-Methylisoxazole)
• 2377033-91-3(Isoxazole, 5-chloro-3-(chloromethyl)-)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)